Alnylam Pharmaceuticals · 11 hours ago
Director, Web Technology Lead
Alnylam Pharmaceuticals is the world’s leading RNA interference (RNAi) company, dedicated to transforming the lives of patients through innovative medicines. The Director, Web Technology Lead will serve as the strategic and technical owner of Alnylam’s global web ecosystem, focusing on evaluating capabilities, defining a web platform strategy, and ensuring compliance and performance standards are met.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Conduct a comprehensive current‑state assessment of Alnylam’s global web technology stack (CMS, hosting, analytics, consent management, DAM, personalization, integrations, and related tools)
Define and maintain a future‑state web platform strategy aligned to global scale, localization needs, performance expectations, and compliance requirements
Establish reference architectures, standards, and technical frameworks for corporate and brand sites across regions
Ensure alignment and interoperability with Alnylam enterprise platforms including CRM, CDP, Marketing Automation, Identity, and Analytics tools
Design and operationalize, in partnership with Customer Experience & Innovation, a scalable global operating model for web technology— balancing central governance with regional agility
Define roles, responsibilities, and working models across relevant cross-functional teams and agency partners
Develop standardized processes and reusable patterns for new site launches, upgrades, migrations, localization, and ongoing website operations
Ensure all web platforms adhere to regulatory, privacy, and security standards (e.g., GxP, GDPR, HIPAA, cookie/consent frameworks)
Lead governance for web change management, release planning, validation approaches, documentation standards, and operational controls
Conduct technology risk assessments and guide remediation activities across the ecosystem
Oversee enterprise web platform operations, including uptime, availability, site performance, incident response, and SLA adherence
Build and manage KPIs for platform health, delivery velocity, quality, cost efficiency, and business value realization
Lead modernization initiatives including CMS/platform upgrades, architectural transitions, and remediation of legacy systems
Manage relationships with CMS providers, hosting platforms, system integrators, and digital agencies
Oversee RFPs, vendor selection, contract negotiations, and performance management
Ensure third‑party partners follow architectural principles, security requirements, and Alnylam’s delivery expectations
Serve as a trusted advisor to senior leaders across Technology, Commercial, Corporate Communications, and regional teams
Communicate complex technical concepts in a clear, accessible manner tailored to non‑technical audiences
Provide leadership to matrixed teams supporting web platforms
Qualification
Required
10+ years of experience in web technology, digital platforms, or enterprise digital solutions, with increasing leadership responsibility
Demonstrated success leading global web platforms within regulated industries (pharma/biotech, healthcare, medical devices, or similarly regulated)
Deep expertise with modern CMS platforms (e.g., Acquia/Drupal, Sitecore, AEM)
Experience with: Cloud hosting (AWS, Azure), CDN, security, and web infrastructure; Web analytics, tag management, and performance measurement; Consent/privacy management tools; DAM integrations and content workflows
Strong understanding of GxP, validation methodologies, security frameworks, and privacy regulations for web ecosystems
Proven ability to define current state, architect future state, and execute transformation roadmaps
Preferred
Experience scaling web platforms in a mid‑size or high‑growth organization
Familiarity with headless, composable, or API‑driven architectures
Hands‑on experience integrating web platforms with CRM, CDP, marketing automation, and personalization systems
Background in agile or product‑oriented delivery models
Bachelor's degree required; advanced degree preferred
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase